MedTrace Logo

Sculptra Aesthetic Post-Approval Study

NCT02425943 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 867

Last updated 2023-07-27

Study results available
· View outcomes & findings →

Summary

Study is designed to assess the long-term safety of Sculptra Aesthetic in immune-competent subjects as a single regimen for correction of nasolabial fold (NLF) contour deficiencies and other facial wrinkles.

Conditions

  • Nasolabial Fold Contour Deficiencies
  • Wrinkles

Interventions

DEVICE

injectable poly-L-lactic acid Sculptra Aesthetic

Sponsors & Collaborators

  • Galderma R&D

    lead INDUSTRY

Principal Investigators

  • Clinical Operations · Galderma R&D

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-21
Primary Completion
2021-05-28
Completion
2021-05-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02425943 on ClinicalTrials.gov